Visalytics
Visalytics
approved EB-2 (NIW) RFE Issued

Research Associate II

Microbiology · Malaysia · 2025-07-17

Processing Time
216 days
Decision Date
2025-07-17
Location
California
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop and apply molecular and genome engineering tools, specifically gene-editing technologies, to study and treat human genetic disorders. This work includes managing microbiome-related diseases and enabling precise genetic interventions for patients with rare genetic conditions to advance personalized medicine.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses pressing health challenges and aligns with the federal Critical and Emerging Technologies list.

2 Well-positioned to Advance the Endeavor Met

The petitioner has a prolific scholarly record including patents, highly-cited publications, and innovative research in droplet microfluidics.

3 Balance of Factors Met

The petitioner’s expertise in molecular medicine is vital to the nation’s scientific competitiveness, justifying a waiver of the job offer requirement.

Why This Petition Was Approved

The approval was supported by 4 peer-reviewed journal articles, 5 conference abstracts, and 2 granted patents. The petitioner's work garnered 178 citations, with papers ranking in the top 10% and 20% of the field. The case successfully demonstrated alignment with the federal Critical and Emerging Technologies list and U.S. national health priorities.

Request for Evidence (RFE)

Successfully Addressed

USCIS issued an RFE during the seven-month processing period, which the legal team addressed by highlighting the client's professional record and innovation in microbiology.

RFE Targets
prong 1 national importanceprong 2 well positionedprong 3 waiver benefit

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Patents
Conference Presentations
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Biotechnology · South Korea

WeGreened EB-2 (NIW) approved
California 249 days 2025-05-28
The petitioner proposes to develop advanced biological tools for genetic and molecular cell interfacing, specifically focusing on high-precision CRISPR base editors and synthetic protein biomarkers. This work aims to refine viral vector delivery systems to enable targeted, non-invasive gene therapies for complex neurological diseases.
View Case

Others

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 64 days 2025-02-15
The petitioner proposes to develop and implement advanced synthetic biology and genetic engineering techniques to precisely control gene expression and cellular behavior in mammalian cells. Her work aims to enhance therapeutic applications and biotechnological advancements to address critical healthcare challenges, specifically rising cancer rates in the U.S.
View Case

Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
Connecticut 45 days 2025-06-05
The petitioner proposes to develop biologically informed machine learning algorithms to analyze genomic sequencing data and identify CRISPR gene targets to map the genetic basis of diseases and guide next-generation gene-editing technologies.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
Illinois 36 days 2025-09-05
The petitioner proposes to develop cutting-edge genomic technologies to understand the functions of non-coding RNAs. This research aims to uncover their roles in human disease and repurpose them as programmable tools for biotechnology and therapeutic applications.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Malaysia

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-07-17.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 216 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Malaysia All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist